The estimated Net Worth of Paul E. Szurek is at least $69.5 Milion dollars as of 15 March 2021. Mr. Szurek owns over 7,524 units of Cencora stock worth over $57,247,208 and over the last 14 years he sold COR stock worth over $6,892,080. In addition, he makes $5,385,070 as President, Chief Executive Officer a Director at Cencora.
Paul has made over 18 trades of the Cencora stock since 2015, according to the Form 4 filled with the SEC. Most recently he sold 7,524 units of COR stock worth $885,876 on 15 March 2021.
The largest trade he's ever made was selling 14,788 units of Cencora stock on 3 March 2021 worth over $1,607,160. On average, Paul trades about 741 units every 18 days since 2010. As of 15 March 2021 he still owns at least 242,347 units of Cencora stock.
You can see the complete history of Mr. Szurek stock trades at the bottom of the page.
Paul E. Szurek serves as President, Chief Executive Officer, Director of the Company. Mr. Szurek has served as our President and Chief Executive Officer since September 2016, and as a director since September 2010. From 2003 to August 2016, Mr. Szurek was Chief Financial Officer of Biltmore Farms, LLC ("Biltmore Farms"), a residential and commercial real estate development and operating company. Prior to joining Biltmore Farms, Mr. Szurek served as Chief Financial Officer of Security Capital Group Incorporated, a publicly traded real estate investment, development and operating company with extensive REIT engagement. Mr. Szurek is currently a director of Four Corners Property Trust, a REIT focused on restaurant real estate. He has also previously served as a director of the Charlotte, North Carolina branch of the Federal Reserve Bank of Richmond and as a director to two publicly traded real estate companies, Regency Centers and Security Capital U.S. Realty. Mr. Szurek received a J.D. with honors from Harvard Law School and a B.A. in Government, magna cum laude, from the University of Texas at Austin. In determining Mr. Szurek's qualifications to serve on our Board, the Board considered, among other things, Mr. Szurek's significant experience concerning the acquisition, disposition, financing, operations and market opportunities of private and publicly traded REITs, which provide us with valuable insight into REIT-industry trends that affect our business. In addition, Mr. Szurek provides valuable insight to the Board based on the day-to-day operations and issues he encounters as our President and Chief Executive Officer.
As the President, Chief Executive Officer a Director of Cencora, the total compensation of Paul Szurek at Cencora is $5,385,070. There are no executives at Cencora getting paid more.
Paul Szurek is 59, he's been the President, Chief Executive Officer a Director of Cencora since 2016. There are 4 older and 10 younger executives at Cencora. The oldest executive at Cencora Inc. is David Wilson, 79, who is the Lead Independent Director.
Paul's mailing address filed with the SEC is C/O CORESITE REALTY CORPORATION, 1001 17TH STREET, SUITE 500, DENVER, CO, 80202.
Over the last 14 years, insiders at Cencora have traded over $67,682,023 worth of Cencora stock and bought 34,206 units worth $1,080,918 . The most active insiders traders include Realty Iii, Gp, L.L.C.Carly..., Iv Aiv Gp, L.L.C.Crp Iv Aiv... a Group Management L.L.C.Carl.... On average, Cencora executives and independent directors trade stock every 13 days with the average trade being worth of $18,365,869. The most recent stock trade was executed by Brian Warren on 5 November 2021, trading 850 units of COR stock currently worth $130,577.
amerisourcebergen is driving innovative partnerships with global manufacturers, providers and pharmacies to improve product access and efficiency throughout the healthcare supply chain and enhance patient care. as the leader in global sourcing and distribution, we source and distribute brand, generic, specialty, otc pharmaceuticals and other healthcare products. we increase the effectiveness and efficiency of your supply chain by ensuring products are delivered securely, consistently and cost-effectively, improving product access for pharmacies, providers and patients. our pharmacy solutions result in greater operational efficiency, cost control, growth opportunities and patient safety. our provider solutions drive operational efficiency, financial performance and improve quality of care. our manufacturer solutions maximize success at every stage of the product lifecycle. amerisourcebergen. where knowledge, reach and partnership shape healthcare delivery.
Cencora executives and other stock owners filed with the SEC include: